ArticleNanoscale advances2024
Core-shell niobium(v) oxide@molecularly imprinted polythiophene nanoreceptors for transformative, real-time creatinine analysis.
Article in Nanoscale advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Metal oxide-polymer hybrid composites: a comprehensive review on synthesis and multifunctional applications.RSC advances · 2025Review
- Niobium-Decorated Multiwalled Carbon Nanotubes for Voltammetric Detection of Paracetamol.ACS omega · 2025Article
- Molecularly imprinted nanocomposites-based synthetic antibodies for uric acid-specific non-invasive electrochemical gout sensors.Mikrochimica acta · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Creatinine, a byproduct of muscle metabolism, is typically filtered by the kidneys. Deviations from normal concentrations of creatinine in human saliva serve as a crucial biomarker for renal diseases. Monitoring these levels becomes particularly essential for individuals undergoing dialysis and those with kidney conditions. This study introduces an innovative disposable point-of-care (PoC) sensor device designed for the prompt detection and continuous monitoring of trace amounts of creatinine. The sensor employs a unique design, featuring a creatinine-imprinted polythiophene matrix combined with niobium oxide nanoparticles. These components are coated onto a screen-printed working electrode. Thorough assessments of creatinine concentrations, spanning from 0 to 1000 nM in a redox solution at pH 7.4 and room temperature, are conducted using cyclic voltammetry (CV), differential pulse voltammetry (DPV), and electrochemical impedance spectroscopy (EIS). The devised sensor exhibits a sensitivity of 4.614 μA cm
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.